nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—LTK—mouth—autistic disorder	0.0172	0.043	CbGeAlD
Erlotinib—ULK3—mouth—autistic disorder	0.00938	0.0234	CbGeAlD
Erlotinib—NR1I2—digestive system—autistic disorder	0.00763	0.019	CbGeAlD
Erlotinib—MAP2K5—hindbrain—autistic disorder	0.0074	0.0184	CbGeAlD
Erlotinib—LTK—head—autistic disorder	0.00623	0.0155	CbGeAlD
Erlotinib—NR1I2—head—autistic disorder	0.00623	0.0155	CbGeAlD
Erlotinib—JAK3—digestive system—autistic disorder	0.0061	0.0152	CbGeAlD
Erlotinib—ULK3—eye—autistic disorder	0.00597	0.0149	CbGeAlD
Erlotinib—ULK3—forebrain—autistic disorder	0.00591	0.0147	CbGeAlD
Erlotinib—EGFR—telencephalon—autistic disorder	0.00588	0.0146	CbGeAlD
Erlotinib—ABL1—hindbrain—autistic disorder	0.00571	0.0142	CbGeAlD
Erlotinib—PIP4K2C—telencephalon—autistic disorder	0.0057	0.0142	CbGeAlD
Erlotinib—MKNK1—eye—autistic disorder	0.00562	0.014	CbGeAlD
Erlotinib—ULK3—telencephalon—autistic disorder	0.00544	0.0135	CbGeAlD
Erlotinib—AURKC—head—autistic disorder	0.00537	0.0134	CbGeAlD
Erlotinib—MKNK1—telencephalon—autistic disorder	0.00512	0.0128	CbGeAlD
Erlotinib—AURKC—nervous system—autistic disorder	0.0051	0.0127	CbGeAlD
Erlotinib—JAK3—head—autistic disorder	0.00498	0.0124	CbGeAlD
Erlotinib—EPHA6—head—autistic disorder	0.00498	0.0124	CbGeAlD
Erlotinib—AURKC—central nervous system—autistic disorder	0.00491	0.0122	CbGeAlD
Erlotinib—SLK—telencephalon—autistic disorder	0.00485	0.0121	CbGeAlD
Erlotinib—JAK3—nervous system—autistic disorder	0.00472	0.0118	CbGeAlD
Erlotinib—EPHA6—nervous system—autistic disorder	0.00472	0.0118	CbGeAlD
Erlotinib—HIPK4—brain—autistic disorder	0.00456	0.0114	CbGeAlD
Erlotinib—JAK3—central nervous system—autistic disorder	0.00454	0.0113	CbGeAlD
Erlotinib—EPHA6—central nervous system—autistic disorder	0.00454	0.0113	CbGeAlD
Erlotinib—MAP3K19—head—autistic disorder	0.00452	0.0113	CbGeAlD
Erlotinib—LTK—brain—autistic disorder	0.00451	0.0112	CbGeAlD
Erlotinib—JAK3—cerebellum—autistic disorder	0.00444	0.0111	CbGeAlD
Erlotinib—MAP3K19—nervous system—autistic disorder	0.00429	0.0107	CbGeAlD
Erlotinib—MAP2K5—brainstem—autistic disorder	0.00424	0.0106	CbGeAlD
Erlotinib—ULK3—digestive system—autistic disorder	0.00415	0.0103	CbGeAlD
Erlotinib—MAP3K19—central nervous system—autistic disorder	0.00413	0.0103	CbGeAlD
Erlotinib—TNK1—cerebellum—autistic disorder	0.00408	0.0102	CbGeAlD
Erlotinib—MKNK1—digestive system—autistic disorder	0.00391	0.00973	CbGeAlD
Erlotinib—AURKC—brain—autistic disorder	0.00389	0.0097	CbGeAlD
Erlotinib—MAP2K5—telencephalon—autistic disorder	0.00376	0.00938	CbGeAlD
Erlotinib—EPHA6—brain—autistic disorder	0.00361	0.00899	CbGeAlD
Erlotinib—JAK3—brain—autistic disorder	0.00361	0.00899	CbGeAlD
Erlotinib—PIP4K2C—head—autistic disorder	0.00355	0.00884	CbGeAlD
Erlotinib—FLT3—cerebellum—autistic disorder	0.0035	0.00873	CbGeAlD
Erlotinib—ULK3—head—autistic disorder	0.00339	0.00844	CbGeAlD
Erlotinib—PIP4K2C—nervous system—autistic disorder	0.00336	0.00838	CbGeAlD
Erlotinib—ABL2—cerebellum—autistic disorder	0.00334	0.00833	CbGeAlD
Erlotinib—TNK1—brain—autistic disorder	0.00331	0.00825	CbGeAlD
Erlotinib—MAP3K19—brain—autistic disorder	0.00328	0.00817	CbGeAlD
Erlotinib—ABL1—brainstem—autistic disorder	0.00327	0.00815	CbGeAlD
Erlotinib—EGFR—cerebellum—autistic disorder	0.00326	0.00813	CbGeAlD
Erlotinib—PIP4K2C—central nervous system—autistic disorder	0.00324	0.00806	CbGeAlD
Erlotinib—STK10—digestive system—autistic disorder	0.00322	0.00802	CbGeAlD
Erlotinib—ULK3—nervous system—autistic disorder	0.00321	0.008	CbGeAlD
Erlotinib—MKNK1—head—autistic disorder	0.00319	0.00794	CbGeAlD
Erlotinib—SLCO2B1—forebrain—autistic disorder	0.00319	0.00794	CbGeAlD
Erlotinib—ABL1—eye—autistic disorder	0.00319	0.00794	CbGeAlD
Erlotinib—PIP4K2C—cerebellum—autistic disorder	0.00316	0.00788	CbGeAlD
Erlotinib—ULK3—central nervous system—autistic disorder	0.00309	0.0077	CbGeAlD
Erlotinib—UGT1A1—digestive system—autistic disorder	0.00304	0.00757	CbGeAlD
Erlotinib—MKNK1—nervous system—autistic disorder	0.00302	0.00753	CbGeAlD
Erlotinib—ULK3—cerebellum—autistic disorder	0.00302	0.00753	CbGeAlD
Erlotinib—CYP1A1—mouth—autistic disorder	0.003	0.00747	CbGeAlD
Erlotinib—SLCO2B1—telencephalon—autistic disorder	0.00293	0.0073	CbGeAlD
Erlotinib—MKNK1—central nervous system—autistic disorder	0.00291	0.00725	CbGeAlD
Erlotinib—ABL1—telencephalon—autistic disorder	0.0029	0.00723	CbGeAlD
Erlotinib—MKNK1—cerebellum—autistic disorder	0.00284	0.00708	CbGeAlD
Erlotinib—ABL2—brain—autistic disorder	0.00272	0.00677	CbGeAlD
Erlotinib—CYP1B1—eye—autistic disorder	0.0027	0.00672	CbGeAlD
Erlotinib—SLK—cerebellum—autistic disorder	0.00269	0.00671	CbGeAlD
Erlotinib—EGFR—brain—autistic disorder	0.00265	0.0066	CbGeAlD
Erlotinib—STK10—head—autistic disorder	0.00262	0.00654	CbGeAlD
Erlotinib—PIP4K2C—brain—autistic disorder	0.00257	0.0064	CbGeAlD
Erlotinib—STK10—nervous system—autistic disorder	0.00249	0.0062	CbGeAlD
Erlotinib—CYP2D6—hindbrain—autistic disorder	0.00247	0.00615	CbGeAlD
Erlotinib—CYP1B1—telencephalon—autistic disorder	0.00246	0.00613	CbGeAlD
Erlotinib—ULK3—brain—autistic disorder	0.00245	0.00611	CbGeAlD
Erlotinib—STK10—central nervous system—autistic disorder	0.0024	0.00597	CbGeAlD
Erlotinib—MAP2K5—head—autistic disorder	0.00234	0.00584	CbGeAlD
Erlotinib—STK10—cerebellum—autistic disorder	0.00234	0.00583	CbGeAlD
Erlotinib—MKNK1—brain—autistic disorder	0.00231	0.00575	CbGeAlD
Erlotinib—SLCO2B1—digestive system—autistic disorder	0.00224	0.00557	CbGeAlD
Erlotinib—MAP2K5—nervous system—autistic disorder	0.00222	0.00554	CbGeAlD
Erlotinib—ABL1—digestive system—autistic disorder	0.00222	0.00552	CbGeAlD
Erlotinib—SLK—brain—autistic disorder	0.00219	0.00545	CbGeAlD
Erlotinib—MAP2K5—central nervous system—autistic disorder	0.00214	0.00533	CbGeAlD
Erlotinib—MAP2K5—cerebellum—autistic disorder	0.00209	0.00521	CbGeAlD
Erlotinib—STK10—brain—autistic disorder	0.0019	0.00474	CbGeAlD
Erlotinib—CYP1B1—digestive system—autistic disorder	0.00188	0.00468	CbGeAlD
Erlotinib—ABCG2—telencephalon—autistic disorder	0.00183	0.00456	CbGeAlD
Erlotinib—SLCO2B1—head—autistic disorder	0.00182	0.00454	CbGeAlD
Erlotinib—ABL1—head—autistic disorder	0.00181	0.0045	CbGeAlD
Erlotinib—ORM1—nervous system—autistic disorder	0.0018	0.00449	CbGeAlD
Erlotinib—ORM1—central nervous system—autistic disorder	0.00174	0.00433	CbGeAlD
Erlotinib—SLCO2B1—nervous system—autistic disorder	0.00173	0.00431	CbGeAlD
Erlotinib—ABL1—nervous system—autistic disorder	0.00171	0.00427	CbGeAlD
Erlotinib—MAP2K5—brain—autistic disorder	0.0017	0.00423	CbGeAlD
Erlotinib—SLCO2B1—central nervous system—autistic disorder	0.00166	0.00415	CbGeAlD
Erlotinib—ABL1—central nervous system—autistic disorder	0.00165	0.00411	CbGeAlD
Erlotinib—SLCO2B1—cerebellum—autistic disorder	0.00163	0.00405	CbGeAlD
Erlotinib—ABL1—cerebellum—autistic disorder	0.00161	0.00402	CbGeAlD
Erlotinib—CYP1B1—head—autistic disorder	0.00153	0.00381	CbGeAlD
Erlotinib—CYP1B1—nervous system—autistic disorder	0.00145	0.00362	CbGeAlD
Erlotinib—CYP2D6—brainstem—autistic disorder	0.00141	0.00352	CbGeAlD
Erlotinib—CYP1B1—central nervous system—autistic disorder	0.0014	0.00348	CbGeAlD
Erlotinib—CYP1B1—cerebellum—autistic disorder	0.00137	0.0034	CbGeAlD
Erlotinib—CYP2D6—forebrain—autistic disorder	0.00137	0.0034	CbGeAlD
Erlotinib—CYP1A2—digestive system—autistic disorder	0.00135	0.00335	CbGeAlD
Erlotinib—CYP1A1—digestive system—autistic disorder	0.00133	0.00331	CbGeAlD
Erlotinib—SLCO2B1—brain—autistic disorder	0.00132	0.00329	CbGeAlD
Erlotinib—ABL1—brain—autistic disorder	0.00131	0.00326	CbGeAlD
Erlotinib—CYP3A5—digestive system—autistic disorder	0.0013	0.00323	CbGeAlD
Erlotinib—CYP2D6—telencephalon—autistic disorder	0.00126	0.00313	CbGeAlD
Erlotinib—ALB—brain—autistic disorder	0.00121	0.00301	CbGeAlD
Erlotinib—CYP1B1—brain—autistic disorder	0.00111	0.00276	CbGeAlD
Erlotinib—CYP1A1—head—autistic disorder	0.00108	0.0027	CbGeAlD
Erlotinib—CYP1A1—nervous system—autistic disorder	0.00103	0.00256	CbGeAlD
Erlotinib—ABCG2—cerebellum—autistic disorder	0.00102	0.00253	CbGeAlD
Erlotinib—CYP1A1—central nervous system—autistic disorder	0.000988	0.00246	CbGeAlD
Erlotinib—ABCB1—forebrain—autistic disorder	0.000982	0.00245	CbGeAlD
Erlotinib—CYP3A4—digestive system—autistic disorder	0.000974	0.00243	CbGeAlD
Erlotinib—CYP2D6—digestive system—autistic disorder	0.000958	0.00239	CbGeAlD
Erlotinib—ABCB1—telencephalon—autistic disorder	0.000903	0.00225	CbGeAlD
Erlotinib—CYP2C8—brain—autistic disorder	0.00085	0.00212	CbGeAlD
Erlotinib—ABCG2—brain—autistic disorder	0.000826	0.00206	CbGeAlD
Erlotinib—CYP1A1—brain—autistic disorder	0.000785	0.00195	CbGeAlD
Erlotinib—CYP2D6—head—autistic disorder	0.000782	0.00195	CbGeAlD
Erlotinib—CYP3A4—nervous system—autistic disorder	0.000753	0.00188	CbGeAlD
Erlotinib—CYP2D6—nervous system—autistic disorder	0.000741	0.00185	CbGeAlD
Erlotinib—CYP3A4—central nervous system—autistic disorder	0.000725	0.00181	CbGeAlD
Erlotinib—CYP2D6—central nervous system—autistic disorder	0.000714	0.00178	CbGeAlD
Erlotinib—CYP2D6—cerebellum—autistic disorder	0.000697	0.00174	CbGeAlD
Erlotinib—ABCB1—digestive system—autistic disorder	0.000689	0.00172	CbGeAlD
Erlotinib—CYP2D6—brain—autistic disorder	0.000566	0.00141	CbGeAlD
Erlotinib—ABCB1—head—autistic disorder	0.000562	0.0014	CbGeAlD
Erlotinib—ABCB1—nervous system—autistic disorder	0.000533	0.00133	CbGeAlD
Erlotinib—ABCB1—central nervous system—autistic disorder	0.000513	0.00128	CbGeAlD
Erlotinib—ABCB1—cerebellum—autistic disorder	0.000502	0.00125	CbGeAlD
Erlotinib—ABCB1—brain—autistic disorder	0.000407	0.00102	CbGeAlD
Erlotinib—ABL1—Hemostasis—HRAS—autistic disorder	2.45e-05	4.09e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MAOB—autistic disorder	2.44e-05	4.08e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.43e-05	4.06e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC25A12—autistic disorder	2.43e-05	4.06e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—SERPINE1—autistic disorder	2.43e-05	4.05e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS2—autistic disorder	2.42e-05	4.04e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADA—autistic disorder	2.42e-05	4.04e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.42e-05	4.04e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—TPH2—autistic disorder	2.41e-05	4.02e-05	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL6—autistic disorder	2.4e-05	4.01e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MTHFR—autistic disorder	2.4e-05	4.01e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—APOE—autistic disorder	2.39e-05	4e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.39e-05	4e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—IL6—autistic disorder	2.39e-05	3.99e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—BCL2—autistic disorder	2.37e-05	3.97e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DPYD—autistic disorder	2.37e-05	3.96e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GPX1—autistic disorder	2.36e-05	3.95e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC19A1—autistic disorder	2.36e-05	3.95e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IFNG—autistic disorder	2.35e-05	3.93e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AVP—autistic disorder	2.35e-05	3.93e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—MAPK1—autistic disorder	2.35e-05	3.92e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—APC—autistic disorder	2.34e-05	3.92e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IGF2—autistic disorder	2.34e-05	3.91e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—EGF—autistic disorder	2.32e-05	3.87e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—DHFR—autistic disorder	2.3e-05	3.84e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.29e-05	3.83e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—DHFR—autistic disorder	2.29e-05	3.82e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—TPH2—autistic disorder	2.27e-05	3.79e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DPYD—autistic disorder	2.23e-05	3.73e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—APOE—autistic disorder	2.23e-05	3.73e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PLA2G4A—autistic disorder	2.21e-05	3.69e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—RORA—autistic disorder	2.21e-05	3.69e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—HRAS—autistic disorder	2.2e-05	3.68e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CACNA1C—autistic disorder	2.2e-05	3.68e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MTHFR—autistic disorder	2.18e-05	3.64e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PIK3CG—autistic disorder	2.16e-05	3.61e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL2—autistic disorder	2.15e-05	3.6e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MEF2C—autistic disorder	2.15e-05	3.59e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HRAS—autistic disorder	2.15e-05	3.59e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—HRAS—autistic disorder	2.13e-05	3.56e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.11e-05	3.53e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—autistic disorder	2.11e-05	3.53e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADSL—autistic disorder	2.11e-05	3.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ITGB3—autistic disorder	2.1e-05	3.5e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL2—autistic disorder	2.09e-05	3.49e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CYP19A1—autistic disorder	2.08e-05	3.47e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.08e-05	3.47e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MAOB—autistic disorder	2.07e-05	3.45e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—XDH—autistic disorder	2.07e-05	3.45e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—autistic disorder	2.06e-05	3.44e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—POMC—autistic disorder	2.06e-05	3.43e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—autistic disorder	2.04e-05	3.41e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—SERPINE1—autistic disorder	2.04e-05	3.41e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—APOE—autistic disorder	2.03e-05	3.39e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—BCL2—autistic disorder	2.03e-05	3.39e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—STX1A—autistic disorder	2.03e-05	3.39e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NPAS2—autistic disorder	2.03e-05	3.39e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—PTEN—autistic disorder	2.03e-05	3.38e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MAPK1—autistic disorder	2.02e-05	3.37e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PIK3CG—autistic disorder	2.01e-05	3.37e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IFNG—autistic disorder	2.01e-05	3.36e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DHFR—autistic disorder	2e-05	3.35e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.97e-05	3.29e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—PTEN—autistic disorder	1.97e-05	3.29e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CYP19A1—autistic disorder	1.96e-05	3.28e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL2—autistic disorder	1.96e-05	3.28e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TCN2—autistic disorder	1.96e-05	3.27e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2A—autistic disorder	1.96e-05	3.27e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL2—autistic disorder	1.96e-05	3.27e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.94e-05	3.24e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—COMT—autistic disorder	1.93e-05	3.23e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.93e-05	3.22e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GSTP1—autistic disorder	1.92e-05	3.22e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—TPH2—autistic disorder	1.92e-05	3.21e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MAOA—autistic disorder	1.92e-05	3.21e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—POMC—autistic disorder	1.92e-05	3.2e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DPYD—autistic disorder	1.89e-05	3.16e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DHFR—autistic disorder	1.89e-05	3.15e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—HRAS—autistic disorder	1.88e-05	3.15e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CAT—autistic disorder	1.87e-05	3.13e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADA—autistic disorder	1.87e-05	3.12e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TSC2—autistic disorder	1.86e-05	3.11e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.84e-05	3.08e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PIK3CG—autistic disorder	1.83e-05	3.06e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—COMT—autistic disorder	1.83e-05	3.05e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LEP—autistic disorder	1.82e-05	3.04e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APOE—autistic disorder	1.82e-05	3.04e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GSTP1—autistic disorder	1.82e-05	3.04e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MAOA—autistic disorder	1.81e-05	3.03e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HRAS—autistic disorder	1.81e-05	3.02e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—autistic disorder	1.8e-05	3.01e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP19A1—autistic disorder	1.8e-05	3.01e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP19A1—autistic disorder	1.79e-05	2.99e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL2—autistic disorder	1.79e-05	2.98e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—autistic disorder	1.78e-05	2.97e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.78e-05	2.97e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAT—autistic disorder	1.77e-05	2.96e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GSTM1—autistic disorder	1.77e-05	2.95e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PLA2G4A—autistic disorder	1.77e-05	2.95e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CACNA1C—autistic disorder	1.76e-05	2.94e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—POMC—autistic disorder	1.74e-05	2.91e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PRKCB—autistic disorder	1.72e-05	2.87e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—RORA—autistic disorder	1.7e-05	2.85e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GPX1—autistic disorder	1.69e-05	2.83e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.69e-05	2.83e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.69e-05	2.82e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.68e-05	2.81e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—PTEN—autistic disorder	1.68e-05	2.81e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—COMT—autistic disorder	1.67e-05	2.8e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GSTM1—autistic disorder	1.67e-05	2.79e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PLA2G4A—autistic disorder	1.67e-05	2.79e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GSTP1—autistic disorder	1.67e-05	2.78e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—COMT—autistic disorder	1.67e-05	2.78e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MAOA—autistic disorder	1.66e-05	2.78e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GSTP1—autistic disorder	1.66e-05	2.77e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MAOA—autistic disorder	1.65e-05	2.76e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MAPK1—autistic disorder	1.65e-05	2.75e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APC—autistic disorder	1.64e-05	2.74e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PIK3CG—autistic disorder	1.64e-05	2.74e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—autistic disorder	1.64e-05	2.74e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—EGF—autistic disorder	1.62e-05	2.71e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAT—autistic disorder	1.62e-05	2.71e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HRAS—autistic disorder	1.62e-05	2.71e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAT—autistic disorder	1.61e-05	2.69e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GPX1—autistic disorder	1.6e-05	2.67e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DHFR—autistic disorder	1.6e-05	2.67e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—MAPK1—autistic disorder	1.6e-05	2.67e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MAOB—autistic disorder	1.6e-05	2.67e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP19A1—autistic disorder	1.57e-05	2.62e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MTHFR—autistic disorder	1.56e-05	2.61e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—POMC—autistic disorder	1.56e-05	2.61e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—autistic disorder	1.55e-05	2.59e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTEN—autistic disorder	1.55e-05	2.59e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PLA2G4A—autistic disorder	1.53e-05	2.56e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GSTM1—autistic disorder	1.53e-05	2.56e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—autistic disorder	1.53e-05	2.56e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GSTM1—autistic disorder	1.52e-05	2.54e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PLA2G4A—autistic disorder	1.52e-05	2.54e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IGF1—autistic disorder	1.5e-05	2.51e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—MAPK1—autistic disorder	1.5e-05	2.51e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—MAPK1—autistic disorder	1.5e-05	2.5e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TPH2—autistic disorder	1.48e-05	2.48e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.48e-05	2.47e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MTHFR—autistic disorder	1.48e-05	2.47e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GPX1—autistic disorder	1.47e-05	2.45e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DPYD—autistic disorder	1.46e-05	2.44e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—COMT—autistic disorder	1.46e-05	2.44e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GPX1—autistic disorder	1.46e-05	2.44e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOE—autistic disorder	1.46e-05	2.43e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTP1—autistic disorder	1.45e-05	2.43e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MAOA—autistic disorder	1.45e-05	2.42e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTEN—autistic disorder	1.43e-05	2.39e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SERPINE1—autistic disorder	1.43e-05	2.38e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAT—autistic disorder	1.41e-05	2.36e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—autistic disorder	1.39e-05	2.32e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—COMT—autistic disorder	1.37e-05	2.3e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOE—autistic disorder	1.37e-05	2.3e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTP1—autistic disorder	1.37e-05	2.29e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—MAPK1—autistic disorder	1.37e-05	2.28e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MAOA—autistic disorder	1.37e-05	2.28e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.36e-05	2.27e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MTHFR—autistic disorder	1.35e-05	2.26e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.35e-05	2.25e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MTHFR—autistic disorder	1.35e-05	2.25e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PLA2G4A—autistic disorder	1.33e-05	2.23e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTM1—autistic disorder	1.33e-05	2.23e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTEN—autistic disorder	1.33e-05	2.23e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAT—autistic disorder	1.33e-05	2.22e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HRAS—autistic disorder	1.32e-05	2.21e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PIK3CG—autistic disorder	1.31e-05	2.19e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HRAS—autistic disorder	1.28e-05	2.15e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GPX1—autistic disorder	1.28e-05	2.13e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—autistic disorder	1.27e-05	2.11e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—MAPK1—autistic disorder	1.26e-05	2.11e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOE—autistic disorder	1.26e-05	2.11e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.26e-05	2.1e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTM1—autistic disorder	1.26e-05	2.1e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOE—autistic disorder	1.25e-05	2.09e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP19A1—autistic disorder	1.25e-05	2.09e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—autistic disorder	1.25e-05	2.09e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PIK3CG—autistic disorder	1.24e-05	2.07e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DHFR—autistic disorder	1.23e-05	2.06e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—autistic disorder	1.23e-05	2.05e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTEN—autistic disorder	1.21e-05	2.03e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—HRAS—autistic disorder	1.21e-05	2.01e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GPX1—autistic disorder	1.2e-05	2.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HRAS—autistic disorder	1.2e-05	2.01e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—autistic disorder	1.18e-05	1.97e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MTHFR—autistic disorder	1.18e-05	1.97e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.18e-05	1.96e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—COMT—autistic disorder	1.16e-05	1.95e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTP1—autistic disorder	1.16e-05	1.94e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MAOA—autistic disorder	1.16e-05	1.93e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2—autistic disorder	1.16e-05	1.93e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—autistic disorder	1.15e-05	1.92e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PIK3CG—autistic disorder	1.14e-05	1.9e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PIK3CG—autistic disorder	1.13e-05	1.89e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAT—autistic disorder	1.13e-05	1.88e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MTHFR—autistic disorder	1.11e-05	1.86e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOE—autistic disorder	1.1e-05	1.83e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HRAS—autistic disorder	1.1e-05	1.83e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PTEN—autistic disorder	1.09e-05	1.82e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—autistic disorder	1.08e-05	1.81e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—autistic disorder	1.08e-05	1.8e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTM1—autistic disorder	1.07e-05	1.78e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PLA2G4A—autistic disorder	1.07e-05	1.78e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—autistic disorder	1.05e-05	1.75e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOE—autistic disorder	1.03e-05	1.73e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GPX1—autistic disorder	1.02e-05	1.7e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—HRAS—autistic disorder	1.01e-05	1.69e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—autistic disorder	9.97e-06	1.67e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PIK3CG—autistic disorder	9.91e-06	1.66e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—autistic disorder	9.7e-06	1.62e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	9.67e-06	1.62e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—autistic disorder	9.43e-06	1.58e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—autistic disorder	9.42e-06	1.57e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MTHFR—autistic disorder	9.41e-06	1.57e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PIK3CG—autistic disorder	9.34e-06	1.56e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—COMT—autistic disorder	8.99e-06	1.5e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTP1—autistic disorder	8.95e-06	1.49e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MAOA—autistic disorder	8.93e-06	1.49e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—autistic disorder	8.89e-06	1.48e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MAPK1—autistic disorder	8.84e-06	1.48e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOE—autistic disorder	8.76e-06	1.46e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAT—autistic disorder	8.71e-06	1.45e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTEN—autistic disorder	8.69e-06	1.45e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—autistic disorder	8.64e-06	1.44e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—autistic disorder	8.59e-06	1.43e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	8.22e-06	1.37e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTM1—autistic disorder	8.22e-06	1.37e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTEN—autistic disorder	8.21e-06	1.37e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PIK3CG—autistic disorder	7.91e-06	1.32e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GPX1—autistic disorder	7.87e-06	1.32e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTEN—autistic disorder	7.53e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—autistic disorder	7.53e-06	1.26e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—autistic disorder	7.52e-06	1.26e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTEN—autistic disorder	7.49e-06	1.25e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MTHFR—autistic disorder	7.27e-06	1.21e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HRAS—autistic disorder	7.09e-06	1.19e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—autistic disorder	7.09e-06	1.18e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—autistic disorder	6.79e-06	1.13e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOE—autistic disorder	6.76e-06	1.13e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTEN—autistic disorder	6.56e-06	1.1e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTEN—autistic disorder	6.18e-06	1.03e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	6.1e-06	1.02e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—autistic disorder	6.01e-06	1e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—autistic disorder	5.81e-06	9.71e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTEN—autistic disorder	5.24e-06	8.75e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—autistic disorder	4.64e-06	7.74e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTEN—autistic disorder	4.04e-06	6.75e-06	CbGpPWpGaD
